Model
Edge
Alexion Pharmaceuticals, Inc.
0000899866
Filing type
8-K
Filing date
Jul 21, 2021
Updated
Jul 22, 2021 ยท 12:11 AM
Copy reference
Filing
8-K
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
Exhibits
EX-3.1
EXHIBIT 3.1
EX-3.2
EXHIBIT 3.2